MELLISSA BINNEY: Open Payments
NPI 1861480881 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 24 payments from 11 companies in 2025. Trend: 2023 $173 · 2024 $574 · 2025 $713
Food & beverage: $630Education: $83
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $232 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Lilly USA, LLC | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Incyte Corporation | 1 | $28 |
| LEO Pharma Inc. | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| LNHC, Inc | 1 | $20 |
Products named: Bimzelx, DUPIXENT, TALTZ, Sotyktu, OPZELURA, ADBRY, ILUMYA, Zoryve.
Industry payments across TX — which companies pay providers there.
